University of Minnesota Pediatric Nephrology

Fellowship · Minneapolis, MN

Topics

Acute Kidney Injury Research 65
Renal Transplantation Outcomes and Treatments 60
Renal Diseases and Glomerulopathies 51
Dialysis and Renal Disease Management 34
Cell Adhesion Molecules Research 17
Metabolism and Genetic Disorders 15
Central Venous Catheters and Hemodialysis 14
Chronic Kidney Disease and Diabetes 13
Innovations in Medical Education 11
Poisoning and overdose treatments 10
Organ Donation and Transplantation 9
Pediatric Urology and Nephrology Studies 9

Most cited

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet (London, England) · 2023 · 246 citations · Michelle Rheault
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Lancet (London, England) · 2023 · 193 citations · Michelle Rheault
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
Nature genetics · 2023 · 171 citations · Michelle Rheault
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
The New England journal of medicine · 2023 · 97 citations · Michelle Rheault
Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024 · 34 citations · Shanthi Balani
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023 · 52 citations · Michelle Rheault
Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy.
JAMA network open · 2024 · 29 citations · Emily Zangla
Factors associated with successful liberation from continuous renal replacement therapy in children and young adults: analysis of the worldwide exploration of renal replacement outcomes collaborative in Kidney Disease Registry.
Intensive care medicine · 2024 · 24 citations · Emily Zangla

Topics

Acute Kidney Injury Research 65

Renal Transplantation Outcomes and Treatments 60

Renal Diseases and Glomerulopathies 51

Dialysis and Renal Disease Management 34

Cell Adhesion Molecules Research 17

Metabolism and Genetic Disorders 15

Central Venous Catheters and Hemodialysis 14

Chronic Kidney Disease and Diabetes 13

Innovations in Medical Education 11

Poisoning and overdose treatments 10

Organ Donation and Transplantation 9

Pediatric Urology and Nephrology Studies 9

Most cited

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.

Lancet (London, England) · 2023 · 246 citations · Michelle Rheault

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.

Lancet (London, England) · 2023 · 193 citations · Michelle Rheault

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

Nature genetics · 2023 · 171 citations · Michelle Rheault

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.

The New England journal of medicine · 2023 · 97 citations · Michelle Rheault

Continuous Kidney Replacement Therapy and Survival in Children and Young Adults: Findings From the Multinational WE-ROCK Collaborative.

American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024 · 34 citations · Shanthi Balani

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.

American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023 · 52 citations · Michelle Rheault

Major Adverse Kidney Events in Pediatric Continuous Kidney Replacement Therapy.

JAMA network open · 2024 · 29 citations · Emily Zangla

Factors associated with successful liberation from continuous renal replacement therapy in children and young adults: analysis of the worldwide exploration of renal replacement outcomes collaborative in Kidney Disease Registry.

Intensive care medicine · 2024 · 24 citations · Emily Zangla